【24h】

乳果糖联合结肠水疗在肝性脑病患者中的应用

机译:乳果糖联合结肠水疗在肝性脑病患者中的应用

获取原文
           

摘要

Abstract:Objective To investigate the effect of lactulose combined with colon hydrotherapy in nursing care of patients with hepatic encephalopathy. Methods  Totally 60 patients with hepatic encephalopathy were assigned to the observation group and the control group, with 30 cases in each group, Both two groups received comprehensive treatment and nursing care, and the lactulose oral solution was give to promote the defecation. In addition, the colon hydrotherapy was carried out in the observation group. The central nervous system symptoms, level of blood ammonia and incidence of adverse reactions were observed and compared between two groups. Results  The overall rate of improvement in central nervous system symptoms was 86.7% in the observation group and was70.0% in the control group, but with no significant difference(P0.05). The level of blood ammonia was decreased in both two groups after intervention, and was lower in the observation group than that of controls(P0.05). There was no significant in incidence of adverse reaction between two groups(P0.05). Conclusion  Lactulose combined with colon hydrotherapy is an effective way of promoting defecation and reducing level of blood ammonia in patients with hepatic encephalopathy.
机译:摘要:目的探讨乳果糖联合结肠水疗在肝性脑病患者护理中的作用。方法将60例肝性脑病患者分为观察组和对照组,每组30例,两组均接受综合治疗和护理,并给予乳果糖口服液促进排便。此外,在观察组中进行了结肠水疗。观察并比较两组中枢神经系统症状,血氨水平和不良反应发生率。结果观察组中枢神经系统症状总体改善率为86.7%,对照组为70.0%,但差异无统计学意义(P> 0.05)。两组干预后血氨水平均降低,观察组低于对照组(P <0.05)。两组不良反应发生率均无统计学意义(P> 0.05)。结论乳果糖联合结肠水疗是促进肝性脑病患者排便,降低血氨水平的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号